The lymphoid chemokine CCL21 triggers LFA-1 adhesive properties on human dendritic cells

Immunology and Cell Biology

Volumn 89, Issue 3, 2011, Pages 458-465

  Eich, Christina ^a   De Vries, I Jolanda M ^a   Linssen, Peter C M ^b   De Boer, Annemiek ^a   Boezeman, Jan B ^b   Figdor, Carl G ^a   Cambi, Alessandra ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

affinity; antigen presenting cell; cell adhesion; integrin; migration

Indexed keywords

INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ARTICLE; BINDING AFFINITY; CANCER PATIENT; CELL ADHESION; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VIVO STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; SHEAR STRESS; VACCINATION;

CELL DIFFERENTIATION; CELL MOVEMENT; CHEMOKINE CCL21; DENDRITIC CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPH NODES; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; PROTEIN BINDING;

EID: 79952816209     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.103     Document Type: Article

References (45)

1. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449: 419-426. (Pubitemid 47509552)
2. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998; 282: 480-483. (Pubitemid 28483676)
3. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat Med 2004; 10: 475-480. (Pubitemid 38667904)
4. Dustin ML, Springer TA. T-cell receptor cross-linking transiently stimulates adhesive-nessthrough LFA-1. Nature 1989; 341: 619-624. (Pubitemid 19257309)
5. Shimaoka M, Takagi J, Springer TA. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct 2002; 31: 485-516. (Pubitemid 34666842)
6. van Kooyk Y, Weder P, Hogervorst F, Verhoeven AJ, van Seventer G, te Velde AA et al. Activation of LFA-1 through a Ca2(+)-dependent epitope stimulates lymphocyte adhe-sion. J Cell Biol 1991; 112: 345-354. (Pubitemid 21909624)
7. Cambi A, Joosten B, Koopman M, de Lange F, Beeren I, Torensma R et al. Organization of the integrin LFA-1 in nanoclusters regulates its activity. Mol Biol Cell 2006; 17: 4270-4281. (Pubitemid 44522048)
8. Shamri R, Grabovsky V, Gauguet JM, Feigelson S, Manevich E, Kolanus W et al. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol 2005; 6: 497-506. (Pubitemid 41716763)
9. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Gettingtothesiteof inflammation: the leukocyte adhesion cascade updated. Nat Rev 2007; 7: 678-689. (Pubitemid 47327397)
10. Luther SA, Tang HL, Hyman PL, Farr AG, Cyster JG. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci USA 2000; 97: 12694-12699.
11. Sozzani S, Allavena P, D'Amico G, Luini W, Bianchi G, Kataura M et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 1998; 161: 1083-1086. (Pubitemid 28380531)
12. Friedman RS, Jacobelli J, Krummel MF. Surface-bound chemokines captureand prime Tcellsforsynapseformation. Nat Immunol 2006; 7: 1101-1108. (Pubitemid 44420655)
13. Johnson LA, Clasper S, Holt AP, Lalor PF, Baban D, Jackson DG. An inflammation-induced mechanism for leukocytetransmigration across lymphatic vessel endothelium. J Exp Med 2006; 203: 2763-2777. (Pubitemid 44833351)
14. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, van Vliet SJ, van Duijnhoven GC, Grabovsky V et al. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol 2000; 1: 353-357.
15. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection ofTcells. Cell 2000; 100: 587-597.
16. De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN et al. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res 2003; 63: 12-17. (Pubitemid 36070411)
17. deVries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellulartherapy. Nat Biotechnol 2005; 23: 1407-1413. (Pubitemid 41679393)
18. Quast T, Tappertzhofen B, Schild C, Grell J, Czeloth N, Forster R et al. Cytohesin-1 controls the activation of RhoA and modulates integrin-dependent adhesion and migration of dendritic cells. Blood 2009; 113: 5801-5810.
19. Bax M, van Vliet SJ, Litjens M, Garcia-Vallejo JJ, van Kooyk Y. Interaction of polysialic acid with CCL21 regulates the migratory capacity of human dendritic cells. PLoS One 2009; 4: e 6987.
20. Salas A, Shimaoka M, Chen S, Carman CV, Springer T. Transition from rolling to firm adhesion is regulated by the conformation of the I domain of the integrin lymphocyte function-associatedantigen-1. J Biol Chem 2002; 277: 50255-50262. (Pubitemid 36042173)
21. Kannagi R. Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes. Curr Opin Struct Biol 2002; 12: 599-608. (Pubitemid 35449067)
22. Sackstein R. The lymphocyte homingreceptors: gatekeepers of the multistepparadigm. Curr Opin Hematol 2005; 12: 444-450.
23. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E et al. CCR7 coordinates the primary immune response by establishing functional microenviron-ments in secondary lymphoid organs. Cell 1999; 99: 23-33. (Pubitemid 29468627)
24. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004; 21: 279-288. (Pubitemid 39094056)
25. Saeki H, Moore AM, Brown MJ, Hwang ST. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 1999; 162: 2472-2475. (Pubitemid 29309263)
26. de Paz JL, Moseman EA, Noti C, Polito L, von Andrian UH, Seeberger PH. Profiling heparin-chemokine interactions using synthetic tools. ACS Chem Biol 2007; 2: 735-744. (Pubitemid 350285909)
27. Laudanna C, Campbell JJ, Butcher EC Role of Rho in chemoattractant- activated leukocyte adhesion through integrins. Science 1996; 271: 981-983. (Pubitemid 26066394)
28. Giagulli C, Scarpini E, Ottoboni L, Narumiya S, Butcher EC, Constantin G et al. RhoA and zeta PKC control distinct modalitiesof LFA-1 activation bychemokines: critical role of LFA-1 affinitytriggering in lymphocyte in vivohoming. Immunity 2004; 20: 25-35. (Pubitemid 38134291)
29. Cairo CW, Mirchev R, Golan DE. Cytoskeletal regulation couples LFA-1 conformational changes to receptor lateral mobility and clustering. Immunity 2006; 25: 297-308. (Pubitemid 44224146)
30. Katagiri K, Hattori M, Minato N, Irie S, Takatsu K, Kinashi T. Rap1 isa potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol Cell Biol 2000; 20: 1956-1969. (Pubitemid 30123812)
31. Kolanus W, Nagel W, Schiller B, Zeitlmann L, Godar S, Stockinger H et al. Alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule. Cell 1996; 86: 233-242. (Pubitemid 26286106)
32. Montanez E, Ussar S, Schifferer M, Bosl M, Zent R, Moser M et al. Kindlin-2 controls bidirectional signaling of integrins. Genes Dev 2008; 22: 1325-1330. (Pubitemid 351717522)
33. Tadokoro S, Shattil SJ, Eto K, Tai V, Liddington RC, de Pereda JM et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science 2003; 302: 103-106. (Pubitemid 37210697)
34. Zhou X, Li J, Kucik DF. The microtubule cytoskeleton participates in control of beta2 integrin avidity. J Biol Chem 2001; 276: 44762-44769.
35. Kohout TA, Nicholas SL, Perry SJ, Reinhart G, Junger S, Struthers RS. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J Biol Chem 2004; 279: 23214-23222. (Pubitemid 38685628)
36. Woolf E, Grigorova I, Sagiv A, Grabovsky V, Feigelson SW, Shulman Z et al. Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces. Nat Immunol 2007; 8: 1076-1085. (Pubitemid 47423755)
37. Xu H, Guan H, Zu G, Bullard D, Hanson J, Slater M et al. The roleof ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur J Immunol 2001; 31: 3085-3093. (Pubitemid 32994560)
38. Lammermann T, Bader BL, Monkley SJ, Worbs T, Wedlich-Soldner R, Hirsch K et al. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 2008; 453: 51-55. (Pubitemid 351630331)
39. Nakano H, Yanagita M, Gunn MD. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 2001; 194: 1171-1178. (Pubitemid 32995786)
40. Keizer GD, Visser W, Vliem M, Figdor CG. A monoclonal antibody (NKI-L16) directed against a unique epitope on the alpha-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions. J Immunol 1988; 140:1393-1400.
41. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 1996; 196: 137-151. (Pubitemid 26306735)
42. Verdijk P, Scheenen TW, Lesterhuis WJ, Gambarota G, Veltien AA, Walczak P et al. Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellularcancervaccines. Int J Cancer 2007; 120: 978-984. (Pubitemid 46214296)
43. deVries IJ, Eggert AA, Scharenborg NM, Vissers JL, Lesterhuis WJ, Boerman OC et al. Phenotypical and functional characterization of clinical grade dendritic cells. J Immunother 2002; 25: 429-438.
44. Verdijk P, Aarntzen EH, Lesterhuis WJ, Boullart AC, Kok E, van Rossum MM et al. Limited amounts ofdendritic cells migrate into theT-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin Cancer Res 2009; 15: 2531-2540.
45. Geijtenbeek TB, van Kooyk Y, van Vliet SJ, Renes MH, Raymakers RA, Figdor CG. High frequencyof adhesion defects in B-lineageacute lymphoblastic leukemia. Blood 1999; 94: 754-764. (Pubitemid 29323890)